UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients

British journal of dermatology (1951), 2011-03, Vol.164 (3), p.645-647

2011

Volltextzugriff (PDF)

Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study

Journal of the European Academy of Dermatology and Venereology, 2014-02, Vol.28 (2), p.246-249

2014

Volltextzugriff (PDF)

P89 HEAT SHOCK FACTOR 1 (HSF1) IS DOWNREGULATED IN RADIOFREQUENCY ABLATED MICE WITH SECONDARY LIVER CANCER PRETREATED WITH NANOLIPOSOMAL shRNA-HSF1

Journal of hepatology, 2014-04, Vol.60 (1), p.S96-S96

2014

Volltextzugriff (PDF)

The importance of stressful family events in psoriatic patients: a retrospective study

Journal of the European Academy of Dermatology and Venereology, 2012-10, Vol.26 (10), p.1236-1239

2012

Volltextzugriff (PDF)

Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression

Digestive and liver disease, 2016-02, Vol.48, p.e8-e9

2016

Volltextzugriff (PDF)

P287 HEPATIC C6-CERAMIDE NANOLIPOSOMAL UPTAKE AFFECTS MCD-INDUCED NASH IN VIVO VIA ALTERATIONS IN PROLIFERATIVE, FIBROTIC AND OXIDATIVE STRESS SIGNALING PATHWAYS

Journal of hepatology, 2014-04, Vol.60 (1), p.S161-S161

2014

Volltextzugriff (PDF)

The AAA+ ATPase Ruvbl1 coordinates liver metabolism and hepatocellular carcinoma progression

Digestive and liver disease, 2015-02, Vol.47, p.e8-e8

2015

Volltextzugriff (PDF)

Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies

Current medical research and opinion, 2009-09, Vol.25 (9), p.2311-2316

2009

Volltextzugriff (PDF)

Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case report

Dermatologic therapy, 2009-07, Vol.22 (4), p.386-390

2009

Volltextzugriff (PDF)

Hepatocyte-specific deletion of RuvBL1 leads to chronic liver damage and regeneration, enhancing HCC development

Journal of hepatology, 2018-04, Vol.68, p.S46-S47

2018

Volltextzugriff (PDF)

PS-081 - Hepatocyte-specific deletion of RuvBL1 leads to chronic liver damage and regeneration, enhancing HCC development

Journal of hepatology, 2018-04, Vol.68, p.S46-S47

2018

Volltextzugriff (PDF)

Efalizumab-induced severe thrombocytopenia can be resolved

Biologics, 2008-01, Vol.2 (4), p.923-927

Prignano, Francesca

2008

Volltextzugriff (PDF)

Loss of hepatic RuvBL1 accelerates DEN-induced carcinogenesis due to chronic liver damage and regeneration

Digestive and liver disease, 2018-02, Vol.50 (1), p.15-16

2018

Volltextzugriff (PDF)

225 The complex between the beta1 integrin and hERG1 potassium channels as a new molecular target in antineoplastic therapy

European journal of cancer supplements, 2010, Vol.8 (5), p.59-59

2010

Volltextzugriff (PDF)

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients: Anti-TNF-α in patients with HBV or HCV and psoriasis

British journal of dermatology (1951), 2011-02, p.no-no

2011

Volltextzugriff (PDF)

P661 Comparable clinical efficacy, safety and immunogenicity of infliximab biosimilar (CT-P13) after transition from reference infliximab (Remicade®) in children with established inflammatory bowel disease: a multi-centre prospective observational study

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S418-S418

2017

Volltextzugriff (PDF)

Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies

Current Medical Research and Opinion, 2009, Vol.25 (9), p.2311-2316

2009

Volltextzugriff (PDF)

A bioengineered approach to re-create and study the extracellular matrix-immune cell crosstalk in normal and fibrotic liver

Journal of hepatology, 2022-07, Vol.77, p.S480

2022

Volltextzugriff (PDF)

Potential Infectious Risk in Dialysis Water: an Italian Pilot Study

European journal of public health, 2018-11, Vol.28 (suppl_4)

2018

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(18)
Berichte
(1)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(6)
Science & Technology
(6)
Adult
(5)
Humans
(5)
Psoriasis
(5)
Dermatology
(4)
Gastroenterology And Hepatology
(4)
Male
(4)
Retrospective Studies
(4)
Aged
(3)
Antibodies, Monoclonal - Therapeutic Use
(3)
Etanercept
(3)
Female
(3)
Immunoglobulin G - Therapeutic Use
(3)
Middle Aged
(3)
Psoriasis - Complications
(3)
Psoriasis - Drug Therapy
(3)
Receptors, Tumor Necrosis Factor - Therapeutic Use
(3)
Biologicals
(2)
Body Weight
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients

Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study

P89 HEAT SHOCK FACTOR 1 (HSF1) IS DOWNREGULATED IN RADIOFREQUENCY ABLATED MICE WITH SECONDARY LIVER CANCER PRETREATED WITH NANOLIPOSOMAL shRNA-HSF1

The importance of stressful family events in psoriatic patients: a retrospective study

Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression

P287 HEPATIC C6-CERAMIDE NANOLIPOSOMAL UPTAKE AFFECTS MCD-INDUCED NASH IN VIVO VIA ALTERATIONS IN PROLIFERATIVE, FIBROTIC AND OXIDATIVE STRESS SIGNALING PATHWAYS

The AAA+ ATPase Ruvbl1 coordinates liver metabolism and hepatocellular carcinoma progression

Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies

Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case report

Hepatocyte-specific deletion of RuvBL1 leads to chronic liver damage and regeneration, enhancing HCC development

PS-081 - Hepatocyte-specific deletion of RuvBL1 leads to chronic liver damage and regeneration, enhancing HCC development

Efalizumab-induced severe thrombocytopenia can be resolved

Loss of hepatic RuvBL1 accelerates DEN-induced carcinogenesis due to chronic liver damage and regeneration

225 The complex between the beta1 integrin and hERG1 potassium channels as a new molecular target in antineoplastic therapy

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients: Anti-TNF-α in patients with HBV or HCV and psoriasis

P661 Comparable clinical efficacy, safety and immunogenicity of infliximab biosimilar (CT-P13) after transition from reference infliximab (Remicade®) in children with established inflammatory bowel disease: a multi-centre prospective observational study

Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies

A bioengineered approach to re-create and study the extracellular matrix-immune cell crosstalk in normal and fibrotic liver

Potential Infectious Risk in Dialysis Water: an Italian Pilot Study

Suchergebnisse filtern